• A hand with a button displaying a white medical cross symbol, digital interface, and abstract blue and green background.

    Clarity with expertise. Tailored to your needs.

  • Two small glass jars with black and green lids on a light background, with green shamrock shapes overlaying the image.

    Aligned with your budget. Always audit-ready.

  • Scattered pale green pills on a pastel background with leaf shapes.

    Where precision meets peace of mind.

PHARMACOVIGILANCE UNBOXED

Full suite of Pharmacovigilance (PV) and Medical Information (MI) services delivered by a dedicated team of experienced healthcare professionals. From routine activities to the most complex regulatory challenges, our team provides tailored solutions to navigate the evolving PV landscape with confidence.

We bring clarity to complex processes, ensure compliance with regulatory requirements, demonstrate adaptability in an ever-changing environment, and apply deep expertise to deliver safe, effective, and compliant outcomes for our Partners. Serving Clients of all sizes - from global pharmaceutical leaders to mid-sized innovators and emerging startups - we adapt our expertise to deliver tailored solutions.

ClaroPV Services Inc. - Icon of three healthcare professionals with a medical cross symbol in front of them on a teal background.
ClaroPV Services Inc. - A light blue shield icon with a white checkmark inside on a teal background.
ClaroPV Services Inc. - Light blue speech bubble with a white background and a blue lowercase 'i' in the center.

ClaroPV’s Projects at a Glance

Select Successes of
our Experienced Team of PV Experts

100% of ClaroPV supported GVP inspections had FULLY COMPLIANT RATINGS, 100% of ClaroPV clients are audit-ready and inspection-ready, 10+ GVP AUDITS conducted by our experienced auditors annually, NO MAJOR or CRITICAL observations in inspections or audits received since ClaroPVs inception.
A presentation slide titled 'Aggregate Reports, Risk Management Planning' listing points about drug-related aggregate data, including hundreds of reports prepared annually, over 40 RMPs developed for various drugs, analysis supporting risk management planning, risk minimization measures, and effectiveness monitoring, with a background of laboratory equipment.